Back to Cardiology
Cardiologyv2024Evidence-Based

CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk

Calculates stroke risk for patients with atrial fibrillation; similar to CHA₂DS₂-VASc Score but without considering sex. Simplified version recommended in 2024 ESC guidelines to remove complexity of gender-based scoring.

Clinical Input Parameters

years
Range: 18 — 120 years
Clinical Assessment
Awaiting Parameters
cha2ds2 va assessment
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The CHA₂DS₂-VA Score for Atrial Fibrillation Stroke Risk is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

CHA₂DS₂-VA Score = C (1) + H (1) + A₂ (age ≥75: 2) + D (1) + S₂ (2) + V (1) + A (age 65-74: 1). Range: 0-8 points.

Clinical Pearls & Practice Notes

  • Introduced in 2024 ESC guidelines to simplify CHA₂DS₂-VASc by removing sex category
  • Rationale: Female sex as age-dependent rather than independent risk factor
  • Removes complexity for healthcare professionals and patients
  • Includes non-binary and transgender individuals without gender-based scoring
  • Risk of thromboembolism in women has decreased over time (2007-2018)
  • Discrimination ability comparable to CHA₂DS₂-VASc score
  • Score 0: No anticoagulation recommended
  • Score 1: Clinical judgment required - consider individual factors
  • Score ≥2: Oral anticoagulation recommended
  • Consider bleeding risk assessment (HAS-BLED) alongside stroke risk
  • Periodically reassess stroke risk as patient conditions change
  • Maximum possible score is 8 points
  • Applies to nonvalvular atrial fibrillation patients

Evidence & Literature Citations

  1. Lip GYH, Keshishian A, Li X, Hamilton M, Masseria C, Gupta K, Mardekian J, Friend K, Nadkarni A, Pan X, Baser O, Deitelzweig S. Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2018;49(12):2933-2944.
  2. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373-498.
  3. Romiti GF, Pastori D, Rivera-Caravaca JM, et al. Adherence to the 'Atrial Fibrillation Better Care' pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost. 2022;122(3):406-414.
  4. Boriani G, Ruff CT, Kuder JF, et al. Relationship between time to therapeutic anticoagulation and clinical outcomes in atrial fibrillation patients treated with warfarin. Europace. 2021;23(3):334-342.

Score Interpretation Ranges

Low Risk0 – 0 pts

Very low stroke risk

Moderate Risk1 – 1 pts

Low-moderate stroke risk

High Risk2 – 9 pts

High stroke risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.